Quotes 5-day view Delayed London Stock Exchange
06/30/2022
07/01/2022
07/04/2022
07/05/2022
07/06/2022
Date
1148(c)
1145(c)
1139(c)
1130(c)
1166
Last
1 836 204
1 712 641
1 008 244
3 380 982
1 981 626
Volume
-0.95%
-0.26%
-0.52%
-0.79%
+3.19%
Change
Estimated financial data (e) (USD)
Sales 2022
5 330 M
-
-
Net income 2022
485 M
-
-
Net Debt 2022
2 081 M
-
-
P/E ratio 2022
24,7x
Yield 2022
2,54%
Sales 2023
5 584 M
-
-
Net income 2023
637 M
-
-
Net Debt 2023
1 889 M
-
-
P/E ratio 2023
18,5x
Yield 2023
2,77%
Capitalization
12 084 M
12 084 M
-
EV / Sales 2022
2,66x
EV / Sales 2023
2,50x
Nbr of Employees
18 369
Free-Float
98,9%
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipments. Net sales break down by activity sector as follows:
- orthopedic surgery (42.1%): primarily orthopedic implants (hips, knees and shoulders) ;
- sports medicine, arthroscopy and cervicofacial surgery (29.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound...
Ratings of Smith & Nephew Plc
All news about SMITH & NEPHEW PLC
News in other languages on SMITH & NEPHEW PLC
Analyst Recommendations on SMITH & NEPHEW PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SMITH & NEPHEW PLC
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
13,87 $
Average target price
18,06 $
Spread / Average Target
30,2%
Please enable JavaScript in your browser's settings to use dynamic charts.